rs143295007

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_145045.5(ODAD3):​c.148C>T​(p.Pro50Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00361 in 1,614,184 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0039 ( 5 hom., cov: 33)
Exomes 𝑓: 0.0036 ( 20 hom. )

Consequence

ODAD3
NM_145045.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.221

Publications

3 publications found
Variant links:
Genes affected
ODAD3 (HGNC:28303): (outer dynein arm docking complex subunit 3) This gene encodes a protein containing coiled-coil domains. The encoded protein functions in outer dynein arm assembly and is required for motile cilia function. Mutations in this gene result in primary ciliary dyskinesia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2014]
ODAD3 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 30
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003619939).
BP6
Variant 19-11434869-G-A is Benign according to our data. Variant chr19-11434869-G-A is described in ClinVar as Benign. ClinVar VariationId is 241942.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00391 (595/152336) while in subpopulation AMR AF = 0.00477 (73/15308). AF 95% confidence interval is 0.00389. There are 5 homozygotes in GnomAd4. There are 371 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ODAD3NM_145045.5 linkc.148C>T p.Pro50Ser missense_variant Exon 1 of 13 ENST00000356392.9 NP_659482.3
ODAD3NM_001302454.2 linkc.148C>T p.Pro50Ser missense_variant Exon 1 of 11 NP_001289383.1
ODAD3XM_017026241.2 linkc.148C>T p.Pro50Ser missense_variant Exon 1 of 9 XP_016881730.1
ODAD3NM_001302453.1 linkc.82+821C>T intron_variant Intron 1 of 12 NP_001289382.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ODAD3ENST00000356392.9 linkc.148C>T p.Pro50Ser missense_variant Exon 1 of 13 1 NM_145045.5 ENSP00000348757.3

Frequencies

GnomAD3 genomes
AF:
0.00391
AC:
595
AN:
152218
Hom.:
5
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000507
Gnomad AMI
AF:
0.00877
Gnomad AMR
AF:
0.00477
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00103
Gnomad FIN
AF:
0.0231
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00335
Gnomad OTH
AF:
0.00573
GnomAD2 exomes
AF:
0.00429
AC:
1071
AN:
249490
AF XY:
0.00423
show subpopulations
Gnomad AFR exome
AF:
0.000581
Gnomad AMR exome
AF:
0.00266
Gnomad ASJ exome
AF:
0.00159
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0210
Gnomad NFE exome
AF:
0.00383
Gnomad OTH exome
AF:
0.00661
GnomAD4 exome
AF:
0.00358
AC:
5238
AN:
1461848
Hom.:
20
Cov.:
31
AF XY:
0.00355
AC XY:
2581
AN XY:
727226
show subpopulations
African (AFR)
AF:
0.000538
AC:
18
AN:
33480
American (AMR)
AF:
0.00262
AC:
117
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00165
AC:
43
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000800
AC:
69
AN:
86258
European-Finnish (FIN)
AF:
0.0184
AC:
981
AN:
53376
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5768
European-Non Finnish (NFE)
AF:
0.00342
AC:
3808
AN:
1112010
Other (OTH)
AF:
0.00323
AC:
195
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
329
657
986
1314
1643
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
132
264
396
528
660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00391
AC:
595
AN:
152336
Hom.:
5
Cov.:
33
AF XY:
0.00498
AC XY:
371
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.000505
AC:
21
AN:
41574
American (AMR)
AF:
0.00477
AC:
73
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.000865
AC:
3
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4830
European-Finnish (FIN)
AF:
0.0231
AC:
245
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00335
AC:
228
AN:
68026
Other (OTH)
AF:
0.00567
AC:
12
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
28
56
83
111
139
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00299
Hom.:
2
Bravo
AF:
0.00213
TwinsUK
AF:
0.00405
AC:
15
ALSPAC
AF:
0.00415
AC:
16
ESP6500AA
AF:
0.000760
AC:
3
ESP6500EA
AF:
0.00410
AC:
34
ExAC
AF:
0.00361
AC:
437
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00365
EpiControl
AF:
0.00314

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Aug 10, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Primary ciliary dyskinesia 30 Benign:1
Jan 13, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
1.8
DANN
Benign
0.61
DEOGEN2
Benign
0.0054
T;T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.069
N
LIST_S2
Benign
0.64
T;T
MetaRNN
Benign
0.0036
T;T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
1.5
L;.
PhyloP100
-0.22
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-1.1
N;.
REVEL
Benign
0.082
Sift
Benign
0.18
T;.
Sift4G
Benign
0.71
T;T
Polyphen
0.0050
B;.
Vest4
0.14
MVP
0.13
MPC
0.46
ClinPred
0.0049
T
GERP RS
-2.5
PromoterAI
0.035
Neutral
Varity_R
0.034
gMVP
0.18
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143295007; hg19: chr19-11545690; COSMIC: COSV99371195; COSMIC: COSV99371195; API